| Vectors and delivery systems in gene therapy R Gardlik, R Pálffy, J Hodosy, J Lukács, J Turna, P Celec Med Sci Monit 11 (4), 110-121, 2005 | 464 | 2005 |
| On the physiology and pathophysiology of antimicrobial peptides R Pálffy, R Gardlík, M Behuliak, L Kadasi, J Turna, P Celec Molecular medicine 15, 51-59, 2009 | 161 | 2009 |
| Sex differences in experimentally induced colitis in mice: a role for estrogens J Bábíčková, Ľ Tóthová, E Lengyelová, A Bartoňová, J Hodosy, R Gardlík, ... Inflammation 38, 1996-2006, 2015 | 151 | 2015 |
| Bacteria in gene therapy: bactofection versus alternative gene therapy R Palffy, R Gardlik, J Hodosy, M Behuliak, P Reško, J Radvánský, P Celec Gene Therapy 13 (2), 101-105, 2006 | 132 | 2006 |
| Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure P Celec, J Hodosy, M Behuliak, R Pálffy, R Gardlík, L Halčák, I Mucska Sleep and Breathing 16, 393-398, 2012 | 83 | 2012 |
| Melatonin interactions with blood pressure and vascular function during l‐NAME‐induced hypertension L Paulis, O Pechanova, J Zicha, A Barta, R Gardlik, P Celec, J Kunes, ... Journal of pineal research 48 (2), 102-108, 2010 | 71 | 2010 |
| Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy R Gardlik, M Behuliak, R Palffy, P Celec, CJ Li Gene therapy 18 (5), 425-431, 2011 | 68 | 2011 |
| Biological and biomedical aspects of genetically modified food P Celec, M Kukučková, V Renczésová, S Natarajan, R Pálffy, R Gardlík, ... Biomedicine & pharmacotherapy 59 (10), 531-540, 2005 | 65 | 2005 |
| Variability of thiobarbituric acid reacting substances in saliva M Behuliak, R Pálffy, R Gardlík, J Hodosy, L Halčák, P Celec Disease Markers 26 (2), 49-53, 2009 | 60 | 2009 |
| Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease J Babickova, R Gardlik World Journal of Gastroenterology: WJG 21 (40), 11321, 2015 | 59 | 2015 |
| Bacterial vectors and delivery systems in cancer therapy R Gardlik, JH Fruehauf IDrugs 13 (10), 701-706, 2010 | 58 | 2010 |
| Recombinant probiotic therapy in experimental colitis in mice R Gardlik, R Palffy, P Celec Folia biologica 58 (6), 238, 2012 | 45 | 2012 |
| Phages and their role in gastrointestinal disease: focus on inflammatory bowel disease M Maronek, R Link, L Ambro, R Gardlik Cells 9 (4), 1013, 2020 | 44 | 2020 |
| Metalloproteinases in inflammatory bowel diseases M Marônek, I Marafini, R Gardlík, R Link, E Troncone, G Monteleone Journal of Inflammation Research, 1029-1041, 2021 | 43 | 2021 |
| The human mycobiome: colonization, composition and the role in health and disease P Belvoncikova, P Splichalova, P Videnska, R Gardlik Journal of Fungi 8 (10), 1046, 2022 | 41 | 2022 |
| Association between oxidative status and the composition of intestinal microbiota along the gastrointestinal tract M Gyuraszova, A Kovalcikova, R Gardlik Medical hypotheses 103, 81-85, 2017 | 39 | 2017 |
| Cell-free nucleic acids and their emerging role in the pathogenesis and clinical management of inflammatory bowel disease Z Kubiritova, J Radvanszky, R Gardlik International Journal of Molecular Sciences 20 (15), 3662, 2019 | 36 | 2019 |
| Targeting angiogenesis for cancer (gene) therapy R Gardlik, P Celec, M Bernadic Bratisl Lek Listy 112 (8), 428-34, 2011 | 36 | 2011 |
| Sex differences in the effect of resveratrol on DSS‐induced colitis in mice A Wagnerova, J Babickova, R Liptak, B Vlkova, P Celec, R Gardlik Gastroenterology research and practice 2017 (1), 8051870, 2017 | 34 | 2017 |
| Gut dysbiosis and fecal microbiota transplantation in autoimmune diseases P Belvoncikova, M Maronek, R Gardlik International journal of molecular sciences 23 (18), 10729, 2022 | 31 | 2022 |
